CAPTRUST Financial Advisors’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-11,761
| Closed | -$274K | – | 4354 |
|
|
2022
Q2 | $274K | Sell |
11,761
-1,154
| -9% | -$26.9K | ﹤0.01% | 1479 |
|
|
2022
Q1 | $353K | Sell |
12,915
-4,846
| -27% | -$132K | ﹤0.01% | 1340 |
|
|
2021
Q4 | $633K | Hold |
17,761
| – | – | ﹤0.01% | 1009 |
|
|
2021
Q3 | $728K | Buy |
17,761
+100
| +0.6% | +$4.1K | 0.01% | 874 |
|
|
2021
Q2 | $707K | Buy |
17,661
+9,510
| +117% | +$381K | 0.01% | 853 |
|
|
2021
Q1 | $289K | Buy |
8,151
+6,698
| +461% | +$237K | ﹤0.01% | 1249 |
|
|
2020
Q4 | $45K | Buy |
1,453
+1,148
| +376% | +$35.6K | ﹤0.01% | 1882 |
|
|
2020
Q3 | $8K | Buy |
+305
| New | +$8K | ﹤0.01% | 2387 |
|